Supernus Pharmaceuticals (SUPN) Change in Inventory (2012 - 2026)

Supernus Pharmaceuticals (SUPN) has 15 years of Change in Inventory data on file, last reported at $105000.0 in Q1 2026.

• On a quarterly basis, Change in Inventory rose 102.22% year-over-year to $105000.0 in Q1 2026; TTM through Mar 2026 was $12.3 million, a 166.52% increase from a year earlier, with the FY2025 full-year figure at $7.5 million, up 147.46% from the prior year.
• Change in Inventory for Q1 2026 stood at $105000.0, down from $4.2 million in the prior quarter.
• Over the last five years, Change in Inventory for SUPN reached as high as $12.9 million in Q3 2025 and fell as low as -$6.9 million in Q3 2023.
• Historically, Change in Inventory has averaged $208764.7 across 5 years, with a median of -$2.0 million in 2024.
• Across the five-year window, Change in Inventory jumped 489.86% in 2022 and sank 251.42% in 2024, its largest moves.
• Year by year, Change in Inventory stood at $11.6 million in 2022, then slumped by 143.52% to -$5.0 million in 2023, then soared by 36.61% to -$3.2 million in 2024, then jumped by 231.16% to $4.2 million in 2025, then sank by 97.49% to $105000.0 in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $105000.0 in Q1 2026, $4.2 million in Q4 2025, and $12.9 million in Q3 2025.